{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:24:32Z","timestamp":1790907872075,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.jsbmb.2008.03.005","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T15:13:33Z","timestamp":1204902813000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Aldosterone and the vascular system"],"prefix":"10.1016","volume":"109","author":[{"given":"Victoria","family":"Cachofeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Miana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mart\u00edn-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fern\u00e1ndez-Tresguerres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Lahera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2008.03.005_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.HYP.36.4.495","article-title":"Cardiac aldosterone production in genetically hypertensive rats","volume":"36","author":"Takeda","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pharmthera.2005.10.010","article-title":"Rapid actions of aldosterone in vascular health and disease-friend or foe?","volume":"2","author":"Sk\u00f8tt","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib4","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation","volume":"273","author":"Silvestre","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib5","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/en.2004-0081","article-title":"Do human vascular endothelial cells produce aldosterone?","volume":"8","author":"Ahmad","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcripcion via functional mineralocorticoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.HYP.29.1.45","article-title":"Vascular aldosterone in genetically hypertensive rats","volume":"29","author":"Takeda","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib9","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.0000093188.53554.44","article-title":"Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase\u2013dependent nitric oxide synthase activation","volume":"108","author":"Liu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib10","doi-asserted-by":"crossref","first-page":"43060","DOI":"10.1074\/jbc.M308134200","article-title":"Aldosterone stimulates epidermal growth factor receptor expression","volume":"278","author":"Krug","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/en.2004-1130","article-title":"Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels","volume":"146","author":"Michea","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib12","first-page":"H176","article-title":"Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling","volume":"284","author":"Stockand","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.HYP.0000176588.51027.35","article-title":"c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats","volume":"46","author":"Callera","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib15","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1210\/endo-129-6-3305","article-title":"11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids","volume":"129","author":"Walker","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ajh\/7.1.100","article-title":"Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells","volume":"7","author":"Kornel","year":"1994","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1748-1716.2006.01574.x","article-title":"Aldosterone remodels human endothelium","volume":"187","author":"Oberleithner","year":"2006","journal-title":"Acta Physiol. (Oxford)"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.HYP.0000123572.45556.a5","article-title":"Human endothelium: target for aldosterone","volume":"43","author":"Oberleithner","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib19","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1242\/jcs.02886","article-title":"Differential action of steroid hormones on human endothelium","volume":"119","author":"Oberleithner","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199700531-00003","article-title":"Endothelial function: general considerations","volume":"53","author":"Haller","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.0000171479.36880.17","article-title":"Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats","volume":"46","author":"Blanco-Rivero","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/ars.2005.7.1294","article-title":"Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences","volume":"7","author":"Sanz-Rosa","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib26","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","article-title":"Eplerenone inhibits atherosclerosis in nonhuman primates","volume":"46","author":"Takai","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib29","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib30","series-title":"Vascular Endothelium: Physiology, Pathology and Therapeutic Options","first-page":"205","article-title":"The physiology and pathophysiology of the nitric oxide\/superoxide system","author":"M\u00fcnzel","year":"1997"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","article-title":"Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts","volume":"47","author":"Kobayashi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardfail.2006.01.002","article-title":"Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production","volume":"3","author":"Thai","year":"2006","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib33","first-page":"1","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity","volume":"476","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib34","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.95.16.9220","article-title":"Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors","volume":"95","author":"Vasquez-Vivar","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib35","doi-asserted-by":"crossref","first-page":"17625","DOI":"10.1074\/jbc.C100122200","article-title":"Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase","volume":"276","author":"Michell","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib36","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1161\/01.RES.0000102404.81461.25","article-title":"Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface","volume":"93","author":"Ahokas","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0895-7061(04)00811-8","article-title":"Involvement of oxidative stress in the profibrotic action of aldosterone\u2014interaction with the renin-angiotensin system","volume":"17","author":"Iglarz","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib38","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells","volume":"16","author":"Miyata","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Superoxide production and these increases were inhibited by eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib40","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.HYP.37.6.1444","article-title":"ETA receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats","volume":"37","author":"Park","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.HYP.21.3.294","article-title":"Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats","volume":"21","author":"Larivi\u00e8re","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib42","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/en.2004-1674","article-title":"Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells","volume":"146","author":"Sugiyama","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.20.1.67","article-title":"Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses","volume":"20","author":"Ullian","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib44","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.RES.0000106135.02935.E1","article-title":"Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone","volume":"93","author":"Uhrenholt","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib45","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.0000093188.53554.44","article-title":"Aldosterone regulates vascular reactivity\u2014short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation","volume":"108","author":"Liu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.regpep.2004.03.016","article-title":"Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide","volume":"120","author":"Balfagon","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2005.12.003","article-title":"Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats","volume":"134","author":"Marquez-Rodas","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib49","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib50","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10741-005-2346-0","article-title":"Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation","volume":"10","author":"Joffe","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib52","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/01.hjh.0000170379.08214.5a","article-title":"Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB\/IkappaB system","volume":"23","author":"Sanz-Rosa","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib53","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib54","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","article-title":"Nuclear factor kappaB signaling in atherogenesis","volume":"25","author":"de Winther","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib55","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","article-title":"Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKC\u025b-MAPK-p90RSK, and Rho-kinase pathway","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2003-1137","article-title":"Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C","volume":"145","author":"Mihailidou","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib57","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.CIR.0000039328.33137.6C","article-title":"Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone","volume":"106","author":"Lacolley","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib58","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00004872-200105000-00013","article-title":"Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension","volume":"19","author":"Park","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ajh\/7.2.193","article-title":"Vascular structural and functional alterations before and after the development of hypertension in SHR","volume":"7","author":"Rizzoni","year":"1994","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.HYP.28.5.785","article-title":"Vascular hypertrophy and remodeling in secondary hypertension","volume":"28","author":"Rizzoni","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2008.03.005_bib63","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00041552-200103000-00015","article-title":"Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors","volume":"10","author":"Safar","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004872-200105000-00001","article-title":"Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift","volume":"19","author":"Epstein","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib66","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1440-1681.2001.03523.x","article-title":"New perspectives on the role of aldosterone excess in cardiovascular disease","volume":"28","author":"Stowasser","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jsbmb.2008.03.005_bib67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1100\/tsw.2006.68","article-title":"Aldosterone and its blockade: a cardiovascular and renal perspective","volume":"6","author":"Lahera","year":"2006","journal-title":"Sci. World J."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076008000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076008000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:57:19Z","timestamp":1760734639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076008000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":67,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0960076008000502"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2008.03.005","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone and the vascular system","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2008.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}